Health
WHO Immunizes Over 155,000 Migrant Children In South Sudan

By Modupe Gbadeyanka
In response to the poliomyelitis outbreak associated with type 2 circulating vaccine-derived poliovirus (cVDPV2) and ambiguous vaccine derived polio virus (aVDPVs) identified in Unity state, the World Health Organization (WHO), in collaboration with Ministry of Health and partners immunized over 155,000 migrant children under the age of 15 through special vaccination posts.
Type 2 circulating vaccine-derived poliovirus (cVDPV2) and ambiguous vaccine derived polio virus (aVDPVs) was being detected in September 2014 and April 2015 respectively.
Widespread displacement and continual population movements due to ongoing conflict and insecurity, cattle riding as well as perennial flooding have resulted in a setback to the country’s immunization coverage and have exacerbated children’s vulnerability to Type 2 circulating vaccine-derived poliovirus and ambiguous vaccine derived polio virus (aVDPVs), especially those in besieged and hard-to-reach areas.
With the aim to reduce the risk of polio transmission among migrating population, 26 special vaccination posts, were opened in seven states located within and around the conflict affected states comprising of seven intra-state, 10 inter-states and nine inter-countries in seven strategic locations namely: Unity, Jonglei, Upper Nile, Warrap, Central Equatoria, Eastern Equatoria, and Lakes.
In order to stop the outbreak and prevent further spread, over 50 trained community health workers were deployed and have been able to reach 108 201 children under the age of 15 years in 2015 and 47 715 in 2016, with oral polio vaccines, where high numbers of children were reached in Unity state, the epicenter of the first outbreak. This has resulted in a marked reduction in the proportion of first time ever vaccinated children from 9% in 2015 to 4% in 2016 for the same period.
Since the war erupted in South Sudan in December 2013, more than 1.6 million people remain displaced internally, with the majority having fled to remote areas across the country and over 1 million people have fled to neighbouring countries. “The establishment of the special vaccinations posts as an additional strategy in a conflict setting of South Sudan provides greater opportunity for vulnerable population to receive critical interventions that could avert life threatening disease such as disability from poliomyelitis” said the WHO Representative to South Sudan Dr Abdulmumini Usman.
Due to the combined efforts from WHO, Ministry of Health and partners the cVDPV2 outbreak was successfully interrupted and declared over in June 2016.
The fight to end polio is led by the Government of South Sudan, with support from donors and partners, including Rotary International, USAID, WHO, UNICEF, the Bill & Melinda Gates Foundation and governments of the world as well as other partners.
Health
AAN Seeks Swift Government Actions on Albinism Related Health Crisis

By Adedapo Adesanya
The Albinism Association of Nigeria (AAN) has intensified its call for swift actions by government and policymakers over the escalating health crisis facing persons with albinism (PWAs) in Nigeria.
The call came as the world marked World Cancer Day on February 4, 2025 under the theme United by Unique.
In a statement signed by the president of the association, Mrs Bisi Bamishe, the group said, “Our people are dying in silence, with little to no awareness of the immense health challenges we endure, particularly the devastating impact of skin cancer.
“Despite our continuous advocacy efforts, the plight of persons with albinism remains largely unaddressed, and the consequences are dire. Within just a few days, we have lost three of our beloved members to this ravaging disease.”
The group highlighted the graveness of the issue, adding that, many others are battling for their lives without access to proper medical care.
“The grim reality is that the community of persons with albinism in Nigeria is under siege, and urgent action is required to prevent further loss of lives.”
AAN used the calender event to call on the government across several tiers to join the fight and improve their inputs.
“The absence of structured government interventions, including access to free or subsidized skin cancer treatments, preventive measures such as sunscreen distribution, and specialized dermatological care, has left our community in a state of despair. Without immediate action, we will continue to witness the preventable deaths of our members,” the group lamented.
“We call on the federal, state, and local governments, the legislative arms at all levels, well-meaning individuals, local and international donors, and relevant stakeholders to stand with us in the fight against this dreaded disease,” it added.
It also noted that it has not rested on its oars with it’s multiple approach to raise awareness about the pressing health needs of persons with albinism.
“We have engaged policymakers, health authorities, and legislators, urging them to implement sustainable policies that will ensure access to affordable healthcare, routine skin cancer screening, and the provision of lifesaving treatments for affected persons.
“However, the time for mere discussions has passed. We need tangible, swift, and decisive actions to save lives,” the group added.
The association lauded the efforts and responsiveness of the Lagos State government and called on other states to follow in its footsteps.
“We must acknowledge the efforts of some state governors, development partners and NGOs that have done a lot for us. Special appreciation goes to Lagos State Government that has spent over N20 million on skin cancer patients in the last two years as well as provision of sunscreen, hats and umbrellas. We hope other states can follow suit as much as possible.”
Health
Nigeria Tightens Surveillance at Entry Point Amid Fresh Ebola Outbreak

By Adedapo Adesanya
Nigeria has tightened surveillance measures at entry points in the country owing to a fresh outbreak of Ebola disease in Uganda.
Last week, the Ugandan Ministry of Health confirmed the outbreak of the disease with one death and has now followed up with forty-four contacts.
With the latest development, the Director-General of the Nigeria Centre for Disease Control (NCDC), Mr Jide Idris, in an advisory said although Nigeria has not recorded any outbreak of the disease, it is putting in place preventive measures.
“There are no cases of Ebola virus disease in Nigeria. However, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with relevant Ministries, Departments, Agencies, and Partners through the National Emerging Viral Hemorrhagic Diseases (EVHD) Technical Working Group, continues to monitor disease occurrence and has initiated measures to strengthen our preparedness in the country.
“These include the update of our EVD emergency contingency plan, heightened surveillance especially at the points of entry, and optimizing diagnostic capacity for EVD testing in designated laboratories in cities with international airports of entry and the National Reference Laboratory. In addition, all Lassa Fever testing laboratories can be activated to scale up testing if the need arises.”
According to the NCDC DG, there are no Ebola vaccines in Nigeria at the moment.
“There are vaccines and therapeutics available for some strains of the Ebola virus. The approved vaccine for the Zaire species (EBV) is not currently available in the country but can be obtained from the WHO Afro and does not protect against the Sudan virus,” he said.
However, the NCDC boss said, “Early recognition, isolation of patients, and initiation of supportive treatment, implementing infection and control measures in health facilities and homes, tracing and monitoring of contacts, and safe burial practices, significantly reduce morbidity and the probability of death.”
Ebola disease is a severe, and often fatal disease caused by the Ebola virus. It is transmitted to humans via contact with wild animals and spreads through human-to-human transmission via direct contact with bodily fluids of infected individuals or contaminated surfaces.
Symptoms may include fever, fatigue, muscle pain, headache, vomiting, diarrhoea, internal and external bleeding. It may appear 2 to 21 days after infection. Medical expertise are advised by the NCDC, in regard to this disease.
Health
i3 Shifts 3rd Cohorts Focus to Growth-Stage Healthtechs After Trump’s Orders

By Adedapo Adesanya
Investing in Innovation Africa (i3), a pan-African initiative to support African health-tech startups to commercialise and scale their offerings has decided to make a pivotal change to its third cohort selection to prioritise the immediate support for 5-7 growth-stage companies building the future of pharmacy care in Africa.
This comes after the US State Department’s “stop-work” directive for foreign aid issued on January 25, which is anticipated to impact the distribution of essential medicine in Africa’s healthcare supply chains.
President Donald Trump issued the executive order freezing US foreign development assistance for 90 days upon assuming office.
One of the affected by the order is the US Agency for International Development (USAID), which offers humanitarian and development assistance to other countries, primarily by giving fundings to non-governmental organisations, governments, and others. USAID is crucial in combating HIV/AIDS and other health matters.
According to a statement shared with Business Post on Monday, i3 says the order highlights and intensifies the need for locally-driven, market-creating approaches to health product distribution and service delivery across Africa.
So now the programme funded by the Gates Foundation, MSD, Cencora, Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics, will concentrate its immediate efforts on helping innovative growth-stage startups unlock major partnerships to rapidly expand access to patient care.
Fifteen leading startups will be selected for this cohort including 10 early-stage startups innovating in healthcare delivery or product distribution and five growth-stage startups building the future of pharmacy care.
Early-stage startups will receive a $50,000 grant and growth-stage startups will receive a $225,000 grant to unlock major partnerships that can expand patient access across the continent.
For startups in the cohort, i3 aims to facilitate at least 150 relationships with key healthcare organizations, worth at least $30M, which will expand patient access while creating valuable local jobs.
Entries for the 3rd cohort are open until February 28 after which the selected startups will be announced on April 30.
Launched in 2022, i3 has empowered 60 African health innovators across 16 countries, exceeding expectations with 43 per cent women-led and 20 per cent Francophone-led ventures.
-
Feature/OPED5 years ago
Davos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz2 years ago
Estranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years ago
Sort Codes of GTBank Branches in Nigeria
-
Economy2 years ago
Subsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking2 years ago
First Bank Announces Planned Downtime
-
Sports2 years ago
Highest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
-
Technology4 years ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN